EGFP+ pancreatic cancer cells with a partial EMT program (as indicated by CK19+ staining) were documented in the primary tumors (Fig 5B, Appendix Fig S6B), consistent with the findings obtained with KPF;αSMA‐Cre;R26Dual mice (Fig 2). This evidence concerns the gene KRT19 and pancreatic neoplasm.